LATEST

Pfizer Receives FDA Warning
Pfizer Receives FDA WarningA Pfizer plant in Kansas is putting patients at risk, according to the FDA
Rite Aid, Albertsons Expand Naloxone AccessRite Aid and Albertsons expand naloxone Access, hoping to curb the opioid epidemic.
How Did You Participate in Rare Disease Day 2017?Rare Disease Day is held every year on the last day of February to help spread awareness about rare diseases and the people they impact.
Small Doses: The news you need to be the bestA look at four important drug studies and stories that you need to know about.
The Top Six Ways Trump’s Policies Will Impact Pharmacies
The Top Six Ways Trump’s Policies Will Impact PharmaciesHow the new Trump administration will affect everything from the ACA to the FDA.
New Legislation Aims to Prohibit DIR FeesBills have been introduced in both the Senate and House that are aimed at stopping direct and indirect remuneration fees, assuming they are passed.
Independent Pharmacy Cooperative and Pace Alliance Join Together
Independent Pharmacy Cooperative and Pace Alliance Join TogetherIPC and Pace Alliance join together to help the independent pharmacist.
Drug Diversion on the Rise at VA Medical CentersThe Associated Press is reporting that federal authorities are ramping up investigations at VA and federal medical centers due to an increase in diversion of opioids and other problems.
Independent Pharmacy Sued Over Fentanyl Overdose DeathA pharmacy in Pennsylvania allowed a man to pick up his mother's prescription for fentanyl after being told not to allow it, with tragic results.
GPhA Rebrands Itself and Changes its Name to the Association for Accessible MedicinesGPhA, the generic drug industry’s leading trade organization, adopted a new name: the Association for Accessible Medicines (AAM). The new name reflects the organization's mission “to make more medicines more accessible to more people who need them.”

Poll